148 related articles for article (PubMed ID: 36732121)
1. Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Jones DA; Candio P; Shakir R; Ramroth J; Wolstenholme J; Gray AM; Cutter DJ; Ntentas G
Clin Oncol (R Coll Radiol); 2023 May; 35(5):301-310. PubMed ID: 36732121
[TBL] [Abstract][Full Text] [Related]
2. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
[TBL] [Abstract][Full Text] [Related]
3. Is proton beam therapy always better than photon irradiation? Lessons from two cases.
Li MP; Yeo A; Gunewardena R; Drum G; Wiltshire K; Phillips C; Sia J; Wheeler G; Hall L
J Med Radiat Sci; 2024 Apr; 71 Suppl 2(Suppl 2):90-98. PubMed ID: 38504608
[TBL] [Abstract][Full Text] [Related]
4. Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.
Jones DA; Candio P; Shakir R; Ntentas G; Ramroth J; Gray AM; Cutter DJ
Blood Adv; 2022 Feb; 6(3):909-919. PubMed ID: 34872107
[TBL] [Abstract][Full Text] [Related]
5. Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
Ntentas G; Dedeckova K; Andrlik M; Aznar MC; George B; Kubeš J; Darby SC; Cutter DJ
Pract Radiat Oncol; 2019 May; 9(3):179-187. PubMed ID: 30708133
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of proton therapy in treating base of skull chordoma.
Austin AM; Douglass MJJ; Nguyen GT; Dalfsen R; Le H; Gorayski P; Tee H; Penniment M; Penfold SN
Australas Phys Eng Sci Med; 2019 Dec; 42(4):1091-1098. PubMed ID: 31646441
[TBL] [Abstract][Full Text] [Related]
7. Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy.
Edvardsson A; Kügele M; Alkner S; Enmark M; Nilsson J; Kristensen I; Kjellén E; Engelholm S; Ceberg S
Acta Oncol; 2019 Jan; 58(1):95-104. PubMed ID: 30280626
[TBL] [Abstract][Full Text] [Related]
8. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
9. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
[TBL] [Abstract][Full Text] [Related]
10. Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison.
König L; Bougatf N; Hörner-Rieber J; Chaudhri N; Mielke T; Klüter S; Haefner MF; Rieken S; Haberer T; Debus J; Herfarth K
Strahlenther Onkol; 2019 Jul; 195(7):677-687. PubMed ID: 30972453
[TBL] [Abstract][Full Text] [Related]
11. What Can Proton Beam Therapy Achieve for Patients with Pectus Excavatum Requiring Left Breast, Axilla and Internal Mammary Nodal Radiotherapy?
Settatree S; Dunlop A; Mohajer J; Brand D; Mooney L; Ross G; Gulliford S; Harris E; Kirby A
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e570-e577. PubMed ID: 34226114
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy in rectal cancer: A systematic review and meta-analysis.
Fok M; Toh S; Easow J; Fowler H; Clifford R; Parsons J; Vimalachandran D
Surg Oncol; 2021 Sep; 38():101638. PubMed ID: 34340196
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
Sher DJ; Tishler RB; Pham NL; Punglia RS
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):875-882. PubMed ID: 29976499
[TBL] [Abstract][Full Text] [Related]
14. Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
Ntentas G; Dedeckova K; Andrlik M; Aznar MC; Shakir R; Ramroth J; Begum R; Kubeš J; Darby SC; Mikhaeel NG; Cutter DJ
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):913-925. PubMed ID: 34762970
[TBL] [Abstract][Full Text] [Related]
15. A Dosimetric Comparison of Breast Radiotherapy Techniques to Treat Locoregional Lymph Nodes Including the Internal Mammary Chain.
Ranger A; Dunlop A; Hutchinson K; Convery H; Maclennan MK; Chantler H; Twyman N; Rose C; McQuaid D; Amos RA; Griffin C; deSouza NM; Donovan E; Harris E; Coles CE; Kirby A
Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):346-353. PubMed ID: 29483041
[TBL] [Abstract][Full Text] [Related]
16. Proton Beam Therapy for Locally Advanced Head and Neck Tumors: An Analysis of Dosimetric and Clinical Outcomes.
Sheikh S; Kharouta MZ; Pidikiti R; Damico NJ; Choi S; Dorth JA; Mansur DB; Machtay MX; Yao M; Bhatt AD
Am J Clin Oncol; 2022 Feb; 45(2):81-87. PubMed ID: 35073281
[TBL] [Abstract][Full Text] [Related]
17. Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
Li G; Xia YF; Huang YX; Okat D; Qiu B; Doyen J; Bondiau PY; Benezery K; Gao J; Qian CN
BMC Cancer; 2021 Aug; 21(1):944. PubMed ID: 34419008
[TBL] [Abstract][Full Text] [Related]
18. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
[TBL] [Abstract][Full Text] [Related]
19. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
[TBL] [Abstract][Full Text] [Related]
20. Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer.
Brodin NP; Kabarriti R; Schechter CB; Pankuch M; Gondi V; Kalnicki S; Garg MK; Tomé WA
Radiat Oncol; 2021 Jan; 16(1):19. PubMed ID: 33478544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
